CP-132484

N/A

Report date: 2025/01/26 19:36:07

NME

Base Information

Drug NameCP-132484

Drug Alias NameCP-132484

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSerotonin 2 (5-HT2) receptor agonists

TargetsSerotonin 2a (5-HT2a) receptorSerotonin 2 (5-HT2) receptor

Therapy Area/IndicationsNerve Degeneration

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsNerve Degeneration

ATC CodeN/A